Overview

The Pain Pen for Breakthrough Cancer Pain

Status:
Terminated

Trial end date:
2008-05-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see whether injection of hydromorphone through a subcutaneous injection device is more effective in treating breakthrough cancer pain than oral morphine.

Phase:

Phase 3

Details

Lead Sponsor:

Erasmus Medical Center

Treatments:

Hydromorphone